Follow along with the video below to see how to install our site as a web app on your home screen.
Note: This feature currently requires accessing the site using the built-in Safari browser.
Don't miss the opportunity to attend Tinnitus Quest's online Q&A with Dr. Susan Shore and Jon Pearson, CEO of Auricle on October 13. We will hear the latest about the Susan Shore Device.
@Matchbox, are you saying Kv7.1 is more important than Kv7.2/3? I read Kv7.1 is expressed in the inner ear.
Kv7.1 channels also play critical roles in the inner ear, where they mediate K+ flux across the apical membrane of the marginal cells (MCs) of the stria vascularis into the scala media of the cochlear duct.
"The study compound will only be administered once during the clinical trial."
And according to QurAlis' ClinicalTrials.gov page, "This study will be a randomized, double-blind, placebo-controlled single ascending dose (SAD) study."
So participating in this study is probably completely useless for tinnitus & hyperacusis anyway.
Again, I don't know. What are the side effects from the clinical trials? Have you read them or the transcripts? I would think there's a possibility. You won't ever get a medication that is free of side effects for 100% of the population.